CrushSCI.com
151.8Average days
130Median days
57Fastest days
331Longest days
1412025 publications

Paper Review Records

All Paper Review Records

23 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

161 days

Application of Pharmacometric Modelling Towards Precise Dosing in Neonates, Infants and Toddlers: A Scoping Review

Authors
Ana S. Rodríguez-Báez; Nina Kreuzberger; Claire Iannizzi; Kamran Irfan; Frederike Lentz; Anna Krueger; Norbert Benda; Ulrich JaehdeShow moreShow less
Affiliations
1. Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, Bonn, Germany; 2. Biostatistics and Special Pharmacokinetics Unit/Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany; 3. Faculty of Medicine and University Hospital Cologne, Institute of Public Health, University of Cologne, Cologne, Germany; 4. National Institute of Research in Agronomy (INRA), Université d´Avignon et des Pays du Vaucluse, UMR Emmah, Avignon, FranceShow moreShow less
Source PDF DOI Publisher page
159 days

Optimization of Cefotaxime Treatment in Intensive Care Patients: Impact of Inter- and Intra-patient Variability on Pharmacokinetics and Target Attainment

Authors
Anthéa Deschamps; Florence Gattacceca; Olivier Blin; Lionel Velly; Romain GuilhaumouShow moreShow less
Affiliations
1. Aix Marseille University, APHM, INSERM, Service de Pharmacologie Clinique et Pharmacosurveillance, Marseille, France; 2. COMPutational Pharmacology and Clinical Oncology Department, Inria Sophia Antipolis-Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France; 3. Department of Anaesthesiology and Critical Care Medicine, Aix Marseille University, APHM, University Hospital Timone, Marseille, France; 4. Aix Marseille University, CNRS, INT, Institute Neuroscience Timone, UMR7289, Marseille, France; 5. Aix Marseille University, CNRS, INS, Institute Neuroscience Systeme, UMR 1106, Marseille, FranceShow moreShow less
Source PDF DOI Publisher page
123 days

Clinical Pharmacokinetics and Disposition of Imrecoxib

Authors
Shengnan Zhao; Charlie Li; Marlon C. Mallillin; Raimar Löbenberg; Neal M. DaviesShow moreShow less
Affiliations
1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada; 2. China Z. Pharmaceutical Productivity Centre, Beijing, China; 3. Department of Pharmacy, Faculty of Pharmacy, University of Santo Tomas, Manila, PhilippinesShow moreShow less
Source PDF DOI Publisher page
128 days

Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment

Authors
Jingheng Wu; Miaomiao Li; Shuai WangShow moreShow less
Affiliations
1. Department of Functional Neurosurgery of Shengjing Hospital, China Medical University, Shenyang, China; 2. Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China; 3. Tianjin Key Laboratory of Cerebral Blood Flow Reconstruction and Head and Neck Tumor New Technology Translation, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, China; 4. Liaoning Clinical Medical Research Center in Nervous System Disease, Shenyang, China; 5. Shenyang, ChinaShow moreShow less
Source PDF DOI Publisher page
57 days

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis

Authors
Cassandra Weng-Yan Lai; Suzanne A. M. Wenker; Paul W. Groundwater; Justin Beardsley; Gaurav Sutrave; Ricky Hao Chen; Anne-Grete Märtson; Jan-Willem C. AlffenaarShow moreShow less
Affiliations
1. School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 2. Faculty of Science, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands; 3. Sydney Institute for Infectious Diseases, University of Sydney, Sydney, Australia; 4. Department of Infectious Diseases, Westmead Hospital, Westmead, Australia; 5. Sydney Medical School-Westmead, University of Sydney, Sydney, Australia; 6. Department of Hematology, Westmead Hospital, Westmead, Australia; 7. Department of Pharmacy, Westmead Hospital, Westmead, AustraliaShow moreShow less
Source PDF DOI Publisher page
76 days

Exposure–Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma

Authors
Mahipal Sinnollareddy; Kinjal Sanghavi; Leonid Gibiansky; Tommy Li; Matthew Putnins; Mohamed-Eslam F. Mohamed; Poliana Patah; Elena Favaro; Manish Gupta; Apurvasena Parikh; Steven XuShow moreShow less
Affiliations
1. Clinical Pharmacology, AbbVie Inc., North Chicago, USA; 2. Clinical Pharmacology, AbbVie Inc., Irvine, USA; 3. Genmab, Plainsboro, USA; 4. QuantPharm LLC, North Potomac, USA; 5. Genmab, Copenhagen, Denmark; 6. Clinical Pharmacology, AbbVie Inc., South San Francisco, USAShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.